Letters to the Editor

Prognostic impact of pre-treatment immunoglobulin clonal composition in pediatric Blymphoblastic leukemia

Department of Pediatrics, Hematology/Oncology, University of Rochester, Rochester
Adaptive Biotechnologies, Inc., Seattle, WA
Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis
Department of Biostatistics, College of Medicine and Public Health and Health Professions, University of Florida, Gainesville, FL
Department of Pediatrics, Texas Children’s Cancer Center, Baylor College of Medicine, Houston
Division of Hematology/Oncology, Hospital for Sick Children, Faculty of Medicine, University of Toronto, Toronto, ON
Department of Pediatrics, Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Seattle, WA
Adaptive Biotechnologies, Inc., Seattle, WA
Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA
Department of Pediatrics, Texas Children’s Cancer Center, Baylor College of Medicine, Houston
Haematologica Early view Nov 3, 2022 https://doi.org/10.3324/haematol.2022.281146